Wei-xuan Lu

424 total citations
21 papers, 299 citations indexed

About

Wei-xuan Lu is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wei-xuan Lu has authored 21 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Internal Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wei-xuan Lu's work include Venous Thromboembolism Diagnosis and Management (8 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Wei-xuan Lu is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (8 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Wei-xuan Lu collaborates with scholars based in China, United States and South Korea. Wei-xuan Lu's co-authors include Chen Wang, Huaping Dai, Kewu Huang, Yuanhua Yang, Ying H. Shen, Xian-sheng Cheng, Zhenguo Zhai, Zhaozhong Cheng, Lirong Liang and Qi Wu and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Applied Physiology and CHEST Journal.

In The Last Decade

Wei-xuan Lu

21 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei-xuan Lu China 6 186 157 84 82 45 21 299
Daniel Layish United States 7 103 0.6× 61 0.4× 35 0.4× 76 0.9× 87 1.9× 10 237
Christopher J. Godshall United States 12 75 0.4× 172 1.1× 64 0.8× 215 2.6× 108 2.4× 18 473
José Luis Alonso-Martínez Spain 7 104 0.6× 220 1.4× 75 0.9× 40 0.5× 47 1.0× 14 316
C.E.A. Dronkers Netherlands 11 316 1.7× 145 0.9× 68 0.8× 18 0.2× 88 2.0× 22 376
Roxane Heller-Baan Netherlands 4 79 0.4× 46 0.3× 40 0.5× 79 1.0× 19 0.4× 5 179
Jason Salsamendi United States 11 90 0.5× 64 0.4× 147 1.8× 91 1.1× 187 4.2× 40 346
António Leitão Marques Portugal 9 81 0.4× 198 1.3× 53 0.6× 26 0.3× 55 1.2× 36 297
A Pieri Italy 7 135 0.7× 53 0.3× 43 0.5× 22 0.3× 68 1.5× 17 252
G Vogel Germany 5 241 1.3× 264 1.7× 25 0.3× 34 0.4× 106 2.4× 5 350
Chethan Gangireddy United States 4 175 0.9× 138 0.9× 31 0.4× 46 0.6× 71 1.6× 9 248

Countries citing papers authored by Wei-xuan Lu

Since Specialization
Citations

This map shows the geographic impact of Wei-xuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-xuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-xuan Lu more than expected).

Fields of papers citing papers by Wei-xuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-xuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-xuan Lu. The network helps show where Wei-xuan Lu may publish in the future.

Co-authorship network of co-authors of Wei-xuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-xuan Lu. A scholar is included among the top collaborators of Wei-xuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-xuan Lu. Wei-xuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chen, Zhenguo Zhai, Yuanhua Yang, et al.. (2015). Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin. The Clinical Respiratory Journal. 10(5). 596–605. 1 indexed citations
2.
Ji, Yingqun, et al.. (2013). Varied response of the pulmonary arterial endothelium in a novel rat model of venous thromboembolism. Chinese Medical Journal. 126(1). 114–117. 5 indexed citations
3.
Wang, Xiaofang, Wei-xuan Lu, Jun Guo, Li Guo, & Yunjian Zhang. (2012). [Protective effects of rosiglitazone intervention on monocrotaline-induced pulmonary arterial hypertension in rats and related inflammatory mechanisms].. PubMed. 92(30). 2144–7. 2 indexed citations
4.
Zhang, Weihua, Chunping Liu, Yunjian Zhang, et al.. (2012). Additive effect of Tadalafil and Simvastatin on monocrotaline-induced pulmonary hypertension rats. Scandinavian Cardiovascular Journal. 46(6). 374–380. 4 indexed citations
5.
Jin, Jianjun, Juhong Shi, Wei-xuan Lu, & Yuan-jue Zhu. (2011). [Clinical features of pulmonary involvement in patients with microscopic polyangiitis].. PubMed. 34(5). 339–43. 5 indexed citations
6.
Wang, Chen, Zhenguo Zhai, Yuanhua Yang, et al.. (2009). Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial. Respiratory Research. 10(1). 128–128. 21 indexed citations
7.
Wang, Chen, Zhenguo Zhai, Yuanhua Yang, et al.. (2009). Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary Thromboembolism. CHEST Journal. 137(2). 254–262. 176 indexed citations
8.
Zhang, Weihua, Wei-xuan Lu, Yunjian Zhang, et al.. (2009). [Simvastatin prevents the development of pulmonary hypertension in the rats through reduction of inflammation].. PubMed. 89(12). 855–9. 4 indexed citations
9.
Lu, Wei-xuan, et al.. (2009). [Pulmonary embolism in cancer: clinical analysis of 60 cases].. PubMed. 31(7). 550–3. 2 indexed citations
10.
Liu, Chunping, et al.. (2007). [The low molecular weight heparin on rat pulmonary surfactant associated protein A of acute pulmonary embolism].. PubMed. 87(9). 634–6. 1 indexed citations
11.
Ji, Yingqun, et al.. (2006). [The clinical analysis of pulmonary arterial hypertension in connective tissue disease].. PubMed. 45(6). 467–71. 5 indexed citations
12.
Liu, Chunping, Yunjian Zhang, Wei-xuan Lu, et al.. (2005). [The change of pulmonary surfactant associated protein A in acute pulmonary embolism].. PubMed. 28(9). 600–3. 2 indexed citations
13.
Zhang, Yunjian, et al.. (2005). [Study of serum uric acid changes after experimental pulmonary thromboembolism in rats].. PubMed. 17(6). 342–5. 1 indexed citations
14.
Xu, Kai‐Feng, Xiao‐Chun Luo, Yan Chen, et al.. (2003). [The use of Juniper's asthma quality of life questionnaire in Chinese asthmatics].. PubMed. 42(11). 760–3. 11 indexed citations
15.
Lu, Wei-xuan, Yijie Zhang, Bo Hu, Yi Ma, & Yuan-jue Zhu. (2003). [Application of St George's respiratory questionnaire in evaluating the life quality of Chinese patients with chronic obstructive pulmonary disease].. PubMed. 26(4). 195–8. 10 indexed citations
16.
Lu, Wei-xuan, et al.. (2000). [Thrombosis diseases and lung cancer].. PubMed. 23(7). 400–2. 2 indexed citations
17.
Snapper, James R., et al.. (1998). Role of Endothelin in Endotoxin-induced Sustained Pulmonary Hypertension in Sheep. American Journal of Respiratory and Critical Care Medicine. 157(1). 81–88. 31 indexed citations
18.
Snapper, James R., et al.. (1998). Effect of platelet-activating factor-receptor antagonism on endotoxin-induced lung dysfunction in sheep. Journal of Applied Physiology. 84(5). 1610–1614. 6 indexed citations
19.
Snapper, James R., et al.. (1998). Effect of cardiogenic and noncardiogenic pulmonary edema on histamine responsiveness in sheep. Journal of Applied Physiology. 85(5). 1635–1642. 4 indexed citations
20.
Snapper, James R., et al.. (1997). Cyclooxygenase Products Contribute to Endothelin-induced Pulmonary Hypertension and Altered Lung Mechanics in Sheep. Pulmonary Pharmacology & Therapeutics. 10(2). 111–118. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026